Joel Block to Etanercept
This is a "connection" page, showing publications Joel Block has written about Etanercept.
Connection Strength
0.622
-
Retrospective Study of Patients on Etanercept Therapy for Rheumatic Diseases in Patients With Chronic Hepatitis C Virus. J Clin Rheumatol. 2017 Aug; 23(5):252-257.
Score: 0.523
-
Safety of etanercept in patients at high risk for mycobacterial tuberculosis infections. J Rheumatol. 2009 May; 36(5):914-7.
Score: 0.073
-
Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin Infect Dis. 2004 Aug 01; 39(3):295-9.
Score: 0.013
-
Mycobacteria tuberculosis peritonitis associated with etanercept therapy. Clin Exp Rheumatol. 2003 Jul-Aug; 21(4):526.
Score: 0.012